Literature DB >> 20860535

Suppression of HIV replication by antiretroviral therapy reduces TIM-3 expression on HIV-specific CD8(+) T cells.

Afework Kassu, Roland A Marcus, Michelle B D'Souza, Elizabeth A Kelly-McKnight, Brent E Palmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20860535     DOI： 10.1089/aid.2010.0156

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  11 in total

Review 1.  HIV-specific CD8⁺ T cells and HIV eradication.

Authors:  R Brad Jones; Bruce D Walker
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.

Authors:  Tsuyoshi Fujita; Benjamin J Burwitz; Glen M Chew; Jason S Reed; Reesab Pathak; Elizabeth Seger; Kiera L Clayton; James M Rini; Mario A Ostrowski; Naoto Ishii; Marcelo J Kuroda; Scott G Hansen; Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

Review 3.  Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion.

Authors:  Robert L Ferris; Binfeng Lu; Lawrence P Kane
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

4.  Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children.

Authors:  Ravi Tandon; Maria T M Giret; Devi Sengupta; Vanessa A York; Andrew A Wiznia; Michael G Rosenberg; Esper G Kallas; Lishomwa C Ndhlovu; Douglas F Nixon
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

5.  Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.

Authors:  Jennifer A Juno; Andrew T Stalker; Jillian Lm Waruk; Julius Oyugi; Makobu Kimani; Francis A Plummer; Joshua Kimani; Keith R Fowke
Journal:  Retrovirology       Date:  2015-02-13       Impact factor: 4.602

6.  Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.

Authors:  Hongbing Yang; Sandrine Buisson; Giovanna Bossi; Zoë Wallace; Gemma Hancock; Chun So; Rebecca Ashfield; Annelise Vuidepot; Tara Mahon; Peter Molloy; Joanne Oates; Samantha J Paston; Milos Aleksic; Namir J Hassan; Bent K Jakobsen; Lucy Dorrell
Journal:  Mol Ther       Date:  2016-06-06       Impact factor: 11.454

7.  Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression.

Authors:  Fareed Ahmad; Esaki M Shankar; Yean K Yong; Hong Y Tan; Gerrit Ahrenstorf; Roland Jacobs; Marie Larsson; Reinhold E Schmidt; Adeeba Kamarulzaman; Abdul W Ansari
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

Review 8.  The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?

Authors:  Hui Chen; Maha Moussa; Marta Catalfamo
Journal:  Front Immunol       Date:  2020-07-02       Impact factor: 7.561

Review 9.  Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure.

Authors:  Selena Vigano; Sara Bobisse; George Coukos; Matthieu Perreau; Alexandre Harari
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

10.  Soluble T-Cell Immunoglobulin Mucin Domain-3 Is Associated With Hepatitis C Virus Coinfection and Low-Grade Inflammation During Chronic Human Immunodeficiency Virus Infection.

Authors:  Hedda Hoel; Thor Ueland; Malene Hove-Skovsgaard; Hans Jakob Hartling; Marco Gelpi; Thomas Benfield; Henrik Ullum; Annika E Michelsen; Pål Aukrust; Susanne Dam Nielsen; Marius Trøseid
Journal:  Open Forum Infect Dis       Date:  2020-01-29       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.